SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001649094-24-000030
Filing Date
2024-07-03
Accepted
2024-07-03 18:04:11
Documents
3
Period of Report
2024-07-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1720044244.html 3  
1 FORM 3 wk-form3_1720044244.xml 3 2191
2 EX-24 poasection16filings-fure.htm EX-24 4128
3 poasection16filings-fure001.jpg GRAPHIC 249879
  Complete submission text file 0001649094-24-000030.txt   352088
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 3737 MARKET STREET, SUITE 1300 PHILADELPHIA PA 19104
Business Address
Furey John (Reporting) CIK: 0001691218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39323 | Film No.: 241101185